 |
FTI Consulting represents British life sciences company Abcam as it defends its $5.7B takeover by DC-based Danaher, which chalked up $31.5B in fiscal 2022 revenues.
Jonathan Milner, Abcam founder and owner of a 6.15 percent stake, opposes the deal, saying it undervalues the company. He accuses the board of not getting the best price for the company.
Abcam on Oct 5 issued a statement to shareholders, saying it conducted a “robust sales process led by Morgan Stanley and Lazard” that included more than 30 potential buyers.
It said Danaher’s $24.00 per share in cash offer was the “highest and best price received at any point in the process," topping the runner-up $22.50 per share offer.
Milner vows to vote against the deal at the Nov. 6 general meeting and replace members of the board.
ICR Consilium’s Mary-Jane Elliott, Davide Salvi and Matthew Neal represents Milner in Europe, while ICR’s’ Dan McDermott works the US.
Joele Frank handles Crinetics Pharmaceuticals as the specialist for treatments for endocrine diseases agrees to get acquired by Vertex Pharmaceuticals in a deal pegged at $8.8B.
Teneo represents Honeywell spin-off Solstice Advanced Materials as it buys Collected Strategies client Element Solutions in a deal pegged at $14.5B.
Dallas-based Throughline Global Advisors advised Principal Mineral as it acquired Isola Group, maker of copper-clad laminates used in printed circuit boards.
oele Frank works for satellite operator Iridium Communications as it gets acquired by space company Rocket Lab in a deal worth $8B.
Uber’s Mike Lucarelli is moving to NXP Semiconductors as senior VP-investor relations.
